Surprise Surprise: ACOs are Touching More Patients than Expected (INFOGRAPH)

December 5, 2012
| Reprints
A look at how the ACO movement has progressed thus far, and where it's headed
Surprise Surprise: ACOs are Touching More Patients than Expected (INFOGRAPH)

Like many other regulatory provisions, the development and effectiveness of accountable care organizations (ACOs) has come under widespread scrutiny. Skeptics have said both Centers for Medicare & Medicaid Services (CMS)-based and non-CMS-based ACO initiatives will fail to achieve much in the way of cost-savings.

A recent report, called “The ACO Surprise,” from the New York City-based consulting firm Oliver Wyman, has, to the contrary, found that the ACO movement is alive and well and full of promise.  The report indicated that up to 31 million patients are receiving care from provider organizations participating in a “population-oriented, value-based care delivery and reimbursement model,” which is how Oliver Wyman defines ACO as a catch-all term. At this number, the report’s authors say, roughly 10 percent of the population is getting their healthcare through ACOs, which they argue is “remarkably quick growth.”

Furthermore, the report’s authors argue that this climate represents only a fraction of the possible impact ACOs can have on healthcare delivery. With 45 percent of the population living in an area with an ACO, they are “well-positioned to drive change in the marketplace,” the authors say. They add that if providers, payers, and other healthcare entities recognize that an investment, from personnel, strategy, and financial perspectives, in a patient-centered ACO is the path to value-based care, the movement will “change the rules of the game.” Thus far, most ACOs aren’t “real ACOs,” and even those that are ahead of the pack, still have a long way to go.

The report uses several examples to illustrate this, including provider-payer collaborations in California and Massachusetts. To learn more about the report, Healthcare Informatics Associate Editor Gabriel Perna interviewed the report’s co-author, Rick Weil, Ph.D., a partner in Oliver Wyman’s health and life sciences practice, about the surprises, opportunities, and critics of the ACO movement.

Source: Oliver Wyman

Below are excerpts from that interview.

Your report is called the ACO surprise – why is it a surprise that ACOs have had such an impact?

I think what was most surprising to folks when you go back to when the Medicare Shared Savings program was first announced, the reaction from most of the market was fairly tepid at best. People noted it was not economically attractive for hospitals and health system, that there was complexity, uncertainty. The benefits were unclear. Recently, people rightfully pointed out, it’s still fee-for-service, it still is predicated on the system that rewards volume as opposed to value.

A lot of people were surprised at just how many organizations are participating in the program. I think the bigger surprise is that you have to look much more broadly than the Medicare Shared Savings program to get a full appreciation for the impact that program, more appropriately the value-based shift, is having.

Really, the big surprise is, it’s touching a lot more people and a lot more organizations than you would expect, and as you look forward, we’re expecting it to be more than double of where we’re at. The big surprise is just how far the market has come relative to what everyone was talking about when the program was first announced.

How did you determine that 31 million patients are receiving care from an ACO?

We keep track and work with a lot of different organizations across the country, both providers and payers, so we can see from the public announcements who is participating in the different shared savings programs. CMS makes that public. So we know where those organizations are, which markets, how many physicians are in those organizations, and how many patients are in the different primary care service areas. Then we do the same thing on the commercial side. That’s really the underpinnings of the analysis.

The surprise to us was that there was more activity on the commercial ACO side. Commercial payers are moving forward aggressively to value-based healthcare.

What is holding back so called ACOs from being, as you call them, “real ACOs?” What’s the main thing they are missing and what do they have to do to change that?

Page
of 2Next
Topics